Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 10
Submit an article Journal homepage
125
Views
7
CrossRef citations to date
0
Altmetric
Theme: Stents & Devices - Reviews

Drug-coated balloons in interventional cardiology

Francesco GianniniInterventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
,
Charbel NaimInterventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy
,
Charis CostopoulosInterventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy;Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy;Imperial College London, London, UK
,
Azeem LatibInterventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy;Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, ItalyCorrespondence[email protected]
&
Antonio ColomboInterventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy;Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, 48 Via M. Buonarroti, 20145 Milan, Italy
Pages 1379-1391 | Published online: 10 Jan 2014

References

  • Garg S, Serruys PW. Coronary stents: current status. J. Am. Coll. Cardiol. 56(10 Suppl.), S1–S42 (2010).
  • Stettler C, Wandel S, Allemann S et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (9591), 937–948 (2007).
  • Bangalore S, Kumar S, Fusaro M et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation 125 (23), 2873–2891 (2012).
  • Mehilli J, Pache J, Abdel-Wahab M et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. Lancet 378 (9796), 1071–1078 (2011).
  • Kastrati A, Mehilli J, von Beckerath N et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293 (2), 165–171 (2005).
  • Byrne RA, Joner M, Kastrati A. Polymer coatings and delayed arterial healing following drug-eluting stent implantation. Minerva Cardioangiol. 57 (5), 567–584 (2009).
  • Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (11), 1440–1455 (2007).
  • Bhatt DL. Intensifying platelet inhibition--navigating between Scylla and Charybdis. N. Engl J. Med. 357 (20), 2078–2081 (2007).
  • Lemos PA, Hoye A, Goedhart D et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (11), 1366–1370 (2004).
  • Cremers B, Biedermann M, Mahnkopf D, Bohm M, Scheller B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin. Res. Cardiol. 98 (5), 325–330 (2009).
  • Radke PW, Joner M, Joost A et al. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention 7 (6), 730–737 (2011).
  • Axel DI, Kunert W, Goggelmann C et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96 (2), 636–645 (1997).
  • Scheller B, Speck U, Abramjuk C, Bernhardt U, Bohm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110 (7), 810–814 (2004).
  • Scheller B, Speck U, Romeike B et al. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur. Heart J. 24 (15), 1462–1467 (2003).
  • Granada JF, Milewski K, Zhao H et al. Vascular response to zotarolimus-coated balloons in injured superficial femoral arteries of the familial hypercholesterolemic Swine. Circ. Cardiovasc. Interv. 4 (5), 447–455 (2011).
  • Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schomig A. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur. Heart J. 27 (3), 260–266 (2006).
  • Godino C, Furuichi S, Latib A et al. Clinical and angiographic follow-up of small vessel lesions treated with paclitaxel-eluting stents (from the TRUE Registry). Am. J. Cardiol. 102 (8), 1002–1008 (2008).
  • Waksman R, Pakala R. Drug-eluting balloon: the comeback kid? Circ. Cardiovasc. Interv. 2 (4), 352–358 (2009).
  • Unverdorben M, Kleber FX, Heuer H et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 99 (3), 165–174 (2010).
  • Cortese B, Micheli A, Picchi A et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96 (16), 1291–1296 (2010).
  • Serra A. Results of paclitaxel eluting balloon (DIOR) for the treatment of in-stent restenosis and small vessel at 1-year follow-up: insights from the Spanish registry. Paper presented at: EuroPCR Congress. Parigi, France, 18 May 2011.
  • Latib A, Colombo A, Castriota F et al. A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels: The BELLO (Balloon Elution and Late Loss Optimization) Study. J. Am. Coll. Cardiol. 60 (24), 2473–2480 (2012).
  • Nakazawa G, Finn AV, Joner M et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118 (11), 1138–1145 (2008).
  • Joner M, Finn AV, Farb A et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48 (1), 193–202 (2006).
  • De Labriolle A, Pakala R, Bonello L, Lemesle G, Scheinowitz M, Waksman R. Paclitaxel-eluting balloon: from bench to bed. Catheter. Cardiovasc. Interv. 73 (5), 643–652 (2009).
  • Wohrle J, Birkemeyer R, Markovic S et al. Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart 97 (16), 1338–1342 (2011).
  • Herdeg C, Gohring-Frischholz K, Haase KK et al. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation. Circ. Cardiovasc. Interv. 2 (4), 294–301 (2009).
  • Hamm C. Paclitaxel-eluting PTCA-balloon in combination with the Coroflex blue stent vs. the sirolimus coated Cypher stent in the treatment of advanced coronary artery disease; PEPCADIII. Paper presented at: The American Heart Association Scientific Sessions. Orlando, FL, 14 November 2009.
  • Liistro R, Angioli P, S.Grati, et al. Predilatation with drug eluting balloon followed by bare metal stent implantation versus drug eluting stent in the treatment of simple de-novo native coronary stenosis. J. Am. Coll. Cardiol. 58, B5 (2011).
  • Poerner TC, Otto S, Janiak F, Gassdorf J, Figulla HR. A prospective randomized study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6 months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (Octopus TRIAL). J. Am. Coll. Cardiol. 59, E281 (2012).
  • Kaul U. The paclitaxel-eluting PTCA-balloon catheter in combination with a cobalt-chromium stent to treat coronary artery disease in a real world scenario. Presented at: AsiaPCR, Singapore. 12–14 January, 2012.
  • Gutierrez-Chico JL, van Geuns RJ, Koch KT et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention 7 (6), 711–722, (2011).
  • Guagliumi G, Sirbu V, Musumeci G et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. J. Am. Coll. Cardiol. Intrv. 5 (1), 12–20 (2012).
  • Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (17), 2126–2130 (2005).
  • Koh T. Drug-eluting balloon in acute myocardial infarction (DEBAMI) trial. Presented at: Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR). Parigi, France, 17–20 May, 2011.
  • Belkacemi A, Agostoni P, Nathoe HM et al. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes. J. Am. Coll. Cardiol. 59 (25), 2327–2337 (2012).
  • Schaaf R, Vos N, Slagboom T, et al. Paclitaxel-eluting balloon in primary percutaneous coronary intervention in Amsterdam (PAPPA): short term outcome of a pilot study (abstract). J. Am. Coll. Cardiol. 58, B5 (2011).
  • Serra A. The Valentines II trial. Presented at: Cardiovascular Research Technologies (CRT). Washington, DC, 4–7 February, 2012.
  • Woehrle J, Motz W, Moebius-Winkler S, et al. Sequent please worldwide registry: results of paclitaxel coated balloon angioplasty for treatment of de novo coronary artery disease. J. Am. Coll. Cardiol. 59, E331 (2012).
  • Lee CW, Park DW, Lee BK et al. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. Am. J. Cardiol. 97 (4), 506–511 (2006).
  • D'Ascenzo F, Bollati M, Clementi F et al. Incidence and predictors of coronary stent thrombosis: Evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int. J. Cardiol. (2012) ( Epub ahead of print).
  • Sangiorgi G. Drug eluting balloons in very long and diffuse coronary artery disease. Presented at: Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR). Parigi, France, 17–20 May, 2011.
  • Hildick-Smith D, de Belder AJ, Cooter N et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation 121 (10), 1235–1243 (2010).
  • Brar SS, Gray WA, Dangas G et al. Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trials. EuroIntervention 5 (4), 475–484 (2009).
  • Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter. Cardiovasc. Interv. 2008;71 (5), 629–635 (2008).
  • Stella PR, Belkacemi A, Dubois C et al. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial. Catheter. Cardiovasc. Interv. 80 (7), 1138–1146 (2012).
  • Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention 7 ( Suppl. K), 61–65 (2011).
  • Sgueglia GA, Todaro D, Bisciglia A, Conte M, Stipo A, Pucci E. Kissing inflation is feasible with all second-generation drug-eluting balloons. Cardiovasc. Revasc. Med. 12 (5), 280–285 (2011).
  • Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J. Am. Coll. Cardiol. 56 (23), 1897–1907 (2010).
  • Habara S, Mitsudo K, Kadota K et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. J. Am. Coll. Cardiol. Intrv. 4 (2), 149–154 (2011).
  • Waksman R, Cheneau E, Ajani AE et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 107 (13), 1744–1749 (2003).
  • Mehilli J, Byrne RA, Tiroch K et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J. Am. Coll. Cardiol. 55 (24), 2710–2716 (2010).
  • Kleber FX, Mathey DG, Rittger H, Scheller B. How to use the drug-eluting balloon: recommendations by the German consensus group. EuroIntervention 7 ( Suppl. K), 125–128 (2011).
  • Scheller B, Hehrlein C, Bocksch W et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N. Engl. J. Med. 355 (20), 2113–2124 (2006).
  • Scheller B, Hehrlein C, Bocksch W et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin. Res. Cardiol. 97 (10), 773–781 (2008).
  • Scheller B, Clever YP, Kelsch B et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. J. Am. Coll. Cardiol. Intrv. 5 (3), 323–330 (2012).
  • Unverdorben M, Vallbracht C, Cremers B et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119 (23), 2986–2994 (2009).
  • Rittger H, Brachmann J, Sinha A-M et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J. Am. Coll. Cardiol. 59 (15), 1377–1382 (2012).
  • Wohrle J, Zadura M, Mobius-Winkler S et al. SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study. J. Am. Coll. Cardiol. 60 (18), 1733–1738 (2012).
  • Byrne RA, Neumann F-J, Mehilli J et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381(9865), 461–467 (2013).
  • Navarese EP, Austin D, Gurbel PA et al. Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials. Clin. Res. Cardiol. 102 (4), 279–287 (2013).
  • Karnabatidis D, Spiliopoulos S, Katsanos K et al. Below-the-knee drug-eluting stents and drug-coated balloons. Expert Rev. Med. Devices 9(1), 85–94 (2012).
  • Speck U, Scheller B, Abramjuk C et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240 (2), 411–418 (2006).
  • Schnorr B, Kelsch B, Cremers B, Clever YP, Speck U, Scheller B. Paclitaxel-coated balloons - Survey of preclinical data. Minerva Cardioangiol. 58 (5), 567–582 (2010).
  • Kelsch B, Scheller B, Biedermann M et al. Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Investigative radiology 46 (4), 255–263 (2011).
  • Posa A, Hemetsberger R, Petnehazy O et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coronary artery disease 19 (4), 243–247 (2008).
  • Posa A, Nyolczas N, Hemetsberger R et al. Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheter Cardiovasc. Interv. 76 (3), 395–403 (2010).
  • Bondesson P, Lagerqvist B, James SK, Olivecrona GK, Venetsanos D, Harnek J. Comparison of two drug-eluting balloons: a report from the SCAAR registry. EuroIntervention 8 (4), 444–449 (2012).
  • Ali RM, Degenhardt R, Zambahari R et al. Paclitaxel-eluting ballon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus. EuroIntervention 7( Suppl. K), K83–K92 (2011).
  • Wohrle J, Werner GS. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries. Catheter Cardiovasc. Interv. 81 (5), 793–799 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.